BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 5:28:00 PM | Browse: 1050 | Download: 1147
Publication Name World Journal of Clinical Oncology
Manuscript ID 9375
Country United States
Received
2014-02-10 16:36
Peer-Review Started
2014-02-10 21:16
To Make the First Decision
2014-03-12 16:42
Return for Revision
2014-03-20 20:41
Revised
2014-05-07 06:46
Second Decision
2014-05-29 08:55
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-29 09:44
Articles in Press
2014-05-29 11:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-25 11:49
Publish the Manuscript Online
2014-08-01 16:16
ISSN 2218-4333 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Review of the current targeted therapies for non-small-cell lung cancer
Manuscript Source Invited Manuscript
All Author List Kim-Son H Nguyen, Joel W Neal and Heather Wakelee
Funding Agency and Grant Number
Corresponding Author Heather Wakelee, MD, Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States. hwakelee@stanford.edu
Key Words Lung cancer; Non-small cell lung cancer; Targeted therapies; Epidermal growth factor receptor; Epidermal growth factor receptor; Anaplastic lymphoma kinase; Acquired resistance
Core Tip The development of oncogene-directed targeted therapies has significantly changed the treatment of non-small-cell lung cancer. We review the data demonstrating efficacy of small-molecule tyrosine kinase inhibitors against epidermal growth factor receptor, anaplastic lymphoma kinase, ROS1, and other oncogenes. We also discuss the challenge of acquired resistance to these therapies and review promising agents which may overcome resistance.
Publish Date 2014-08-01 16:16
Citation Nguyen KSH, Neal JW, Wakelee H. Review of the current targeted therapies for non-small-cell lung cancer. World J Clin Oncol 2014; 5(4): 576-587
URL http://www.wjgnet.com/2218-4333/full/v5/i4/576.htm
DOI http://dx.doi.org/10.5306/wjco.v5.i4.576
Full Article (PDF) WJCO-5-576.pdf
Full Article (Word) WJCO-5-576.doc
Manuscript File 9375-Review.docx
Answering Reviewers 9375-Answering reviewers.pdf
Copyright License Agreement 9375-Copyright assignment.pdf
Peer-review Report 9375-Peer review(s).pdf
Scientific Misconduct Check 9375-CrossCheck.jpg
Scientific Editor Work List 9375-Scientific editor work list.pdf